✦ LIBER ✦

Rituximab-based novel strategies for the treatment of immune-mediated glomerular diseases

✍ Scribed by Kattah, Andrea G.; Fervenza, Fernando C.; Roccatello, Dario

Book ID: 118066600
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 202 KB
Volume: 12
Category: Article
ISSN: 1568-9972
DOI: 10.1016/j.autrev.2012.09.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab: emerging treatment strategies

Rituximab: emerging treatment strategies of immune-mediated glomerular disease

✍ Kattah, Andrea G; Fervenza, Fernando C 📂 Article 📅 2012 🏛 Expert Reviews 🌐 English ⚖ 934 KB

Alternative strategies other than growth

Alternative strategies other than growth hormone for the treatment of immune diseases

✍ Giuseppe Famularo; Luisa Di Marzio; Salvatore Ulisse; Maria Grazia Cifone; Claud 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 26 KB

Alternative strategies other than growth

Alternative strategies other than growth hormone for the treatment of immune diseases

✍ William J Murphy; Dan L Longo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 26 KB

The effect of rituximab on humoral and c

The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases

✍ Nichola Cooper; Donald M. Arnold 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

P168 Selective inhibition of multiple cy

P168 Selective inhibition of multiple cytokines: A novel therapeutic strategy for immune-mediated diseases

✍ N. Azimi; R. Massoud; S. Jacobson; Y. Tagaya 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Development of gene therapy-based strate

Development of gene therapy-based strategies for the treatment of eye diseases

✍ Piroska E. Rakoczy; Wei-Yong Shen; May Lai; Fabienne Rolling; Ian J. Constable 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

Gene therapy, which is the deliberate transfer of DNA for therapeutic purposes, can be defined as the in situ production of a therapeutical material within the diseased cells. The eye is an ideal target for gene therapy, as it is confined to a small space, separated by the retina-blood barrier from